Publications by authors named "F Anghelina"

Cholesteatoma is an otologic pathology that can occur at any age and can lead to a variety of complications including facial palsy, intracranial abscess, hearing loss, venous thrombosis. Cholesteatoma, even if considered a benign condition, associates high risks of recurrency due to its invasiveness. We describe a case of recurrent cholesteatoma in a young boy who presented chronic ear discharge and hearing loss for which had undergone three surgical interventions between the ages of 16 and 19 years old, from 2019 to 2022.

View Article and Find Full Text PDF

Nasal polyps develop as a result of inflammation of the nasal and sinus mucosa. Allergies and nasal infections cause inflammation, and these are the main reasons why these symptoms appear in the first place. This study highlights the involvement of macrophages, as well as T- and B-lymphocytes, in the pathophysiology of nasal polyps.

View Article and Find Full Text PDF
Article Synopsis
  • Abrocitinib is a JAK1 inhibitor mainly approved for treating moderate-to-severe atopic dermatitis in those 12 and older, but this review explores its off-label uses.
  • Researchers found 37 studies using Abrocitinib for conditions beyond atopic dermatitis, with common cases including vitiligo, prurigo nodularis, and hand eczema, each having 12 reported instances.
  • All but one of the 103 patients studied experienced favorable outcomes with Abrocitinib, highlighting its potential for treating multiple skin conditions.
View Article and Find Full Text PDF

Multiple primary cancers are usually defined as primary malignant tumors of different histological origins in one person. Synchronous cancers are defined as two or more primary cancers diagnosed in the same patient at the same time or within six months after identifying the first tumor, and those cancers that develop at more than a six-month interval are termed as metachronous multiple primary cancers. Our study comprised of a patient with synchronous laryngeal cancer with double localizations.

View Article and Find Full Text PDF
Article Synopsis
  • - The study investigates changes in the causes and characteristics of nosebleed (epistaxis) cases that required hospitalization before and during the COVID-19 pandemic, analyzing data from October 2018 to May 2022 involving 380 cases.
  • - Results showed that more patients with general causes for nosebleeds were admitted during the pandemic, while those without such causes were more common before it; the length of hospital stays also varied, with longer stays seen pre-pandemic.
  • - The findings suggest that the COVID-19 pandemic significantly affected both the number of nosebleed cases and the duration of hospitalization, highlighting shifts in medical trends tied to the global health crisis.
View Article and Find Full Text PDF